Is Taysha Gene Therapies Inc. (TSHA) One of the Must-Buy Penny Stocks to Buy Now?
Taysha Gene Therapies Inc. (NASDAQ:TSHA) is a must-buy penny stock to buy now.
Taysha Gene Therapies Inc. (TSHA)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 23,555,648 | $77,026,969 | 0.95% | |
| 2. | VenBio Select Advisor Kurt Von Emster | 21,700,000 | $70,959,000 | 0.92% | |
| 3. | Siren L.L.C. Raymond Debbane | 11,014,737 | $36,018,190 | 1.41% | |
| 4. | Octagon Capital Advisors Ting Jia | 9,067,500 | $29,650,725 | -28% | 4.49% |
| 5. | Point72 Asset Management Steve Cohen | 7,331,470 | $23,973,907 | +1% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.75 | 750,000 | $2,062,500.00 | 2,841,704 | 2025-05-30 | Filing | |
| $2.25 | 1,333,333 | $2,999,999.25 | 1,333,333 | 2024-06-27 | Filing | |
| $1.63 | 100,000 | $163,000.00 | 16,566,667 | 2023-11-17 | Filing | |
| $0.90 | 16,466,667 | $14,820,000.30 | 16,466,667 | 2023-08-16 | Filing | |
| $0.90 | 388,889 | $350,000.10 | 999,381 | 2023-08-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.51 | 260,047 | $1,172,811.97 | 1,006,439 | 2025-12-01 | Filing | |
| $4.75 | 110,125 | $523,093.75 | 1,006,439 | 2025-11-28 | Filing | |
| $3.23 | 200,000 | $646,000.00 | 1,006,439 | 2025-09-10 | Filing | |
| $2.85 | 57,054 | $162,603.90 | 1,165,289 | 2025-08-21 | Filing | |
| $2.85 | 54,491 | $155,299.35 | 1,187,603 | 2025-08-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 24,354,291 | $79,638,532 | 0.98% | |
| 2. | 19,307,603 | $63,135,862 | 0% | |
| 3. | 16,364,861 | $53,513,096 | 0% | |
| 4. | 14,593,412 | $47,720,458 | 0% | |
| 5. | 13,383,708 | $43,764,725 | 0.01% |
News See All
11 Must-Buy Penny Stocks to Buy Now
Markets have continued to rally, with the S&P 500 already up by about 15% for the year.
12 Best American Penny Stocks to Buy Right Now
The S&P 500 is set to outperform the Russell 2000 in annual performance for the 10th time over the past 12 years.
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q3 2025 Earnings Call Transcript
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q3 2025 Earnings Call Transcript November 4, 2025Taysha Gene Therapies, Inc. misses on earnings expectations.
Taysha Gene Therapies Regains Full Global Rights to Lead Rett Syndrome Program TSHA-102
Taysha Gene Therapies Inc. (NASDAQ:TSHA) is one of the best NASDAQ stocks under $5 to buy now.
Raymond James Initiates Strong Buy on Taysha (TSHA) Amid Rett Syndrome Trial Momentum
Taysha Gene Therapies Inc. (NASDAQ:TSHA) is one of billionaire Steve Cohen’s small-cap stock picks with huge upside potential.
11 Best NASDAQ Stocks Under $5 to Buy Now
On October 9, Scott Ladner, Chief Investment Officer at Horizon Investments, appeared on CNBC to suggest that AI remains the key market driver along with tech.
Billionaire Steve Cohen's 10 Small-Cap Stock Picks with Huge Upside Potential
Known for speed, agility, and a high-risk, high-reward investment approach, Steve Cohen is one of the most successful hedge fund managers on Wall Street.
Taysha Gene Therapies Inc. (TSHA) is ‘Market Perform’ on Rett Syndrome Therapy: JMP Securities
Taysha Gene Therapies Inc. (NASDAQ:TSHA) is one of the best healthcare penny stocks to buy now.
11 Best Healthcare Penny Stocks to Buy Now
The US healthcare sector is one of the biggest in the world, with spending expected to reach $5.3 trillion this year.
Hedge Fund Resource Center Billionaire Hedge Funds
